Seizert Capital Partners LLC Makes New $1.86 Million Investment in Maximus, Inc. $MMS

Seizert Capital Partners LLC purchased a new position in shares of Maximus, Inc. (NYSE:MMS) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 21,588 shares of the health services provider’s stock, valued at approximately $1,863,000.

A number of other institutional investors also recently bought and sold shares of the business. Horizon Investments LLC lifted its holdings in Maximus by 20.0% during the 4th quarter. Horizon Investments LLC now owns 29,312 shares of the health services provider’s stock worth $2,530,000 after buying an additional 4,879 shares during the last quarter. New York State Teachers Retirement System lifted its holdings in Maximus by 6.2% during the 4th quarter. New York State Teachers Retirement System now owns 71,445 shares of the health services provider’s stock worth $6,167,000 after buying an additional 4,183 shares during the last quarter. State of New Jersey Common Pension Fund D increased its position in shares of Maximus by 9.7% during the fourth quarter. State of New Jersey Common Pension Fund D now owns 27,319 shares of the health services provider’s stock worth $2,358,000 after purchasing an additional 2,415 shares in the last quarter. Comerica Bank boosted its position in shares of Maximus by 124.4% in the 4th quarter. Comerica Bank now owns 61,284 shares of the health services provider’s stock valued at $5,290,000 after purchasing an additional 33,973 shares during the period. Finally, Pictet Asset Management Holding SA grew its stake in Maximus by 7.9% during the 4th quarter. Pictet Asset Management Holding SA now owns 8,078 shares of the health services provider’s stock worth $697,000 after buying an additional 590 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Maximus

In related news, Director Jan Madsen sold 742 shares of the stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total transaction of $53,609.50. Following the completion of the sale, the director directly owned 20,795 shares of the company’s stock, valued at $1,502,438.75. This trade represents a 3.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Bruce Caswell acquired 3,175 shares of the stock in a transaction that occurred on Tuesday, February 10th. The stock was purchased at an average price of $78.45 per share, for a total transaction of $249,078.75. Following the completion of the transaction, the chief executive officer owned 328,013 shares in the company, valued at $25,732,619.85. The trade was a 0.98% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 1.80% of the company’s stock.

Maximus Price Performance

Shares of MMS opened at $65.55 on Monday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 2.34 and a current ratio of 2.34. Maximus, Inc. has a fifty-two week low of $60.75 and a fifty-two week high of $100.00. The firm has a 50-day simple moving average of $69.28 and a 200-day simple moving average of $80.41. The company has a market capitalization of $3.58 billion, a price-to-earnings ratio of 9.98 and a beta of 0.60.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.01. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.37 billion. During the same quarter in the previous year, the firm posted $1.61 EPS. The firm’s revenue for the quarter was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, equities research analysts anticipate that Maximus, Inc. will post 8.46 earnings per share for the current year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Friday, May 15th will be paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Friday, May 15th. Maximus’s dividend payout ratio is 20.09%.

Analyst Ratings Changes

Several research analysts have commented on MMS shares. Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Weiss Ratings lowered shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Finally, Zacks Research cut shares of Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company has an average rating of “Hold”.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.